LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
Drug : CARTIA XT
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 74752
Country : US
Patented : No
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Drug : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 22321
Country : US
Patented : Yes
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 200920
Country : US
Patented : No
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Drug : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 77302
Country : US
Patented : No
GLYBURIDE; METFORMIN HYDROCHLORIDE
Drug : GLYBURIDE AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 76716
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 210279
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 215523
Country : US
Patented : No
Drug : DILT-CD
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 76151
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204266
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 202580
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
Controlled Modified Release
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.
Dosage Form : Tablet, Transdermal Patch
Grade : Not Available
Category : Controlled & Modified Release
Application : Controlled & Modified Release
Excipient Details : Acrycoat RL 30 D is used in various controlled & modified release formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Ammonio Methacrylate Copolymer
Dosage Form : Tablet, Transdermal Patch
Grade : Oral and Topical
Category : Controlled & Modified Release
Application : Controlled & Modified Release
Excipient Details : Acrycoat RS 30 D is used in various sustained release formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Ammonio Methacrylate Copolymer Type B
Dosage Form : Tablet, Transdermal Patch
Grade : Oral and Topical
Category : Controlled & Modified Release
Application : Controlled & Modified Release
Excipient Details : Acrycoat RS 100 is used in various sustained release formulations.
Pharmacopoeia Ref : USP/NF: Ammonia Methacrylate C...
Technical Specs : Not Available
Ingredient(s) : Ammonio Methacrylate Copolymer Type B
Dosage Form : Tablet, Transdermal Patch
Grade : Oral and Topical
Category : Controlled & Modified Release
Application : Controlled & Modified Release
Excipient Details : Acrycoat RSPO is used in various sustained release formulations.
Pharmacopoeia Ref : USP/NF: Ammonia Methacrylate C...
Technical Specs : Not Available
Ingredient(s) : Ammonio Methacrylate Copolymer Type B
Solubilizers
